Ryan Allway March 28th, 2022 News, Top News TORONTO, March 28, 2022–(BUSINESS WIRE)–Hempsana Holdings Ltd. (the “Company” or “Hempsana“) a leader in the production and refinement of cannabinoids and Cannabis 2.0 products, is delighted to announce that it has entered into a contract manufacturing agreement with GAMA Corp (“GAMA“)... Read more
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer
March 28, 2022
Ryan Allway March 28th, 2022 News, Top News VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a definitive... Read more
Ryan Allway March 28th, 2022 News, Top News TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has changed its corporate name to “CNBX Pharmaceuticals Inc.” CNBX Pharmaceuticals The Company’s new... Read more
Psychedelic Pharmaceutical Startup Ninnion Announces Formation of World Renowned Scientific Advisory Board
March 28, 2022
Ryan Allway March 28th, 2022 Psychedelics, Top News Board members include industry pioneers Dr. Rick Strassman and Dr. Charles B Nemeroff AUSTIN, TX –News Direct– Ninnion Ninnion, a clinical-stage pharmaceutical company focused on developing next-generation psychedelic therapeutics today announced the formation of its Scientific Advisory Board (SAB). The board... Read more
Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth
March 25, 2022
TORONTO, March 25, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update demonstrating that the Company continues to deliver market share advances by focusing on the highest revenue generating dried flower, pre-roll, and vape product categories. Consumers... Read more
Ryan Allway March 25th, 2022 News, Top News Construction begins on a new state-of-the-art manufacturing facility at Kent Science Park designed to support the manufacture of regulatory approved cannabis-based medicines This represents a significant commitment to the UK by GW Pharmaceuticals, now part of Jazz Pharmaceuticals, investing $100 million (£75m) and... Read more
Ryan Allway March 25th, 2022 News, Top News Entering 2022 well-positioned to execute on wellness strategy focused on Canadian B2B recreational cannabis and North American nutraceuticals TORONTO, March 25, 2022 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that... Read more
Ryan Allway March 24th, 2022 News, Top News Royal Greens Delivery Service Expands Company’s Distribution Reach VANCOUVER, BC / ACCESSWIRE / March 24, 2022 / FinCanna Capital Corp. (“FinCanna“) (“the Company”) (CSE:CALI)(OTCQB:FNNZF) an investment company focused on the U.S. licensed cannabis industry, is pleased to announce that its investee company,... Read more
Real Brands Announces Entry to Medical Psychedelics Market, Partners with Marcu & Arora for Licensure, R&D
CBD March 24, 2022
Ryan Allway March 24th, 2022 Psychedelics, Top News Real Brands applying for DEA psychedelics licensure Psychedelics drugs market size is projected to reach $10.75 billion by 2027 Real Brands planning to leverage new clinical research to produce and deliver safe, nature-based psychedelics product formulations that will effectively treat mental... Read more
Ryan Allway March 24th, 2022 News, Top News Cash balance of $18.9 million as of December 31, 2021 Signed out-licensing deal worth $42.7 million with Ewopharma Phase III psoriasis topline data expected Q2 2022 Namodenoson induced complete response and cleared all cancer lesions in advanced liver cancer patient in Can-Fite’s... Read more
